Position in KRYS
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$359,064
New position
Shares Held
1,390
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026KINGSWOOD WEALTH ADVISORS, LLC holds $3,741,428 across 14 Biotechnology names. KRYS ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,353 | $604,168 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765 | $591,069 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
26,591 | $502,569 | |
| 4 | KRYS |
Krystal Biotech, Inc.
This page
|
1,390 | $359,064 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
10,651 | $295,032 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
9,600 | $260,064 | |
| 7 | ALT |
Altimmune, Inc.
|
76,500 | $235,620 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
14,500 | $214,890 |
All Filings in KRYS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $359,064 | 1,390 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||